Dr. Zorn discusses 3-year data on Aquablation

“I think Aquablation is safe. It’s efficacious, especially in these large prostates,” says Kevin Zorn, MD, FRCSC, FACS.

In this video, Kevin Zorn, MD, FRCSC, FACS, discusses the findings and takeaways of the study, “Aquablation for benign prostatic hyperplasia in large prostates (80-150CC): 3-year results,” which was presented during the 2021 American Urological Association annual meeting. Zorn is an associate professor of urology at the University of Montreal, Canada.

Related Content:

Benign Prostatic HyperplasiaUTv
Questions raised by kidney cancer epidemiology update
Dr. Bukavina and Dr. Psutka share take-homes from kidney cancer epidemiology paper
Breakthrough Advances in Immunotherapy